Is there a role for adjuvant chemotherapy in pathological complete response rectal cancer tumors following neoadjuvant chemoradiotherapy?

Ravit Geva(Tel Aviv Sourasky Medical Center), Eran Itzkovich(Tel Aviv University), Sivan Shamai(Tel Aviv University), Einat Shacham‐Shmueli(Sheba Medical Center), Viacheslav Soyfer(Tel Aviv Sourasky Medical Center), Joseph M. Klausner(Tel Aviv Sourasky Medical Center), Hagit Tulchinsky(Tel Aviv University)
Journal of Cancer Research and Clinical Oncology
May 21, 2014
10.1007/s00432-014-1712-5
Cited by 35Open Access
Full Text

Abstract

Related Papers

Cancer Statistics, 2008
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al.|CA A Cancer Journal for Clinicians|2008|10.2k
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Rolf Sauer, Heinz Becker, Werner Hohenberger et al.|New England Journal of Medicine|2004|6k
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
Monique Maas, Patty J. Nelemans, Vincenzo Valentini et al.|The Lancet Oncology|2010|1.9k
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Bengt Glimelius, Emmanuel Tiret, Andrés Cervantes et al.|Annals of Oncology|2013|1.8k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein et al.|Annals of Oncology|2012|1.5k